Advancing Pharmacogenetics in Pre-clinical Research: Unveiling New Avenues for Precision Medicine
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 113
Special Issue Editors
Interests: pharmacogenetics; pharmacogenomics; precision medicine; acute myeloid leukemia
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pharmacogenetics tailors medical treatments based on individual genetic variations, optimizing drug response, efficacy and safety. Pre-clinical research forms the foundation for translating these findings into clinical practice. This issue aims to explore the latest discoveries in pharmacogenetics, with a focus on pre-clinical research and its impact on precision medicine.
We welcome original research articles and reviews on various aspects of pharmacogenetics in pre-clinical research, including genetic variant identification, mechanistic insights, novel models and methodologies, integrating pharmacogenetic data in drug development and translational challenges. We invite your contributions to advance our understanding of pharmacogenetics and shape personalized therapeutics.
Please, refer to the journal's submission guidelines for manuscript preparation and submission instructions. Contact us with any queries or for further information. Join us in uncovering new avenues for precision medicine!
Dr. Miriam Saiz-Rodrigez
Dr. Shengying Qin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacogenetics
- pharmacogenomics
- precision medicine
- individualized medicine
